PAN or EGPA With FFS=0: Clinical Trials

1 trial for PAN or EGPA With FFS=0, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow PAN or EGPA With FFS=0: new trials by email Literature Review of PAN or EGPA With FFS=0 trials Research Report on PAN or EGPA With FFS=0

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
corticosteroid and azathioprine, corticosteroid and placebo - MPA, PAN or EGPA With FFS=0
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1142008-05-012025-09-12

Narrower conditions

Churg-Strauss Syndrome (1)  ·  Microscopic Polyangiitis (1)  ·  Polyarteritis Nodosa (1)  ·  Vasculitis (1)

Broader conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Arteritis (1)  ·  Autoimmune Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Granuloma (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Nervous System Diseases (1)  ·  Skin Diseases (1)

Interventions

Adrenal Cortex Hormones (1)  ·  Azathioprine (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)

Countries

France (1)

Top investigators

Loic Guillevin, MD, PhD (1)

Results publications

PMID 28678392, PMID 31056661